Cytoplasmic Free Zinc and Increased Reactive Oxygen Species Generation in the Context of Brain Injury



Fig. 1
Intracellular zinc accumulation, as occurs early in excitotoxic conditions, results in the activation of multiple ROS- and RNS-generating mechanisms; which in turn result in further zinc accumulation, leading to cell death. Mitochondrial zinc accumulation leads to the loss of ΔΨm, inhibition of respiration, ROS production, and the development of the mitochondrial permeability transition pore and the promotion of apoptosis through cytochrome c release. NADPH activation by zinc acting through protein kinase C (PKC) represents a particularly robust source of excitotoxic ROS. The direct activation of nNOS and 12-LOX by zinc also represent important sources of oxidative stress and further zinc liberation. DNA damage induced by ROS and RNS generation results in PARP activation and cell death. ROS/RNS elevation induced by zinc can also activate p38 MAPK, which promotes K+ efflux through KV2.1, leading to cell shrinkage and cell death. See text for details



A striking feature of free zinc-induced ROS and RNS generation is that these reactive species interact with cellular targets to oxidatively liberate further zinc. In this way, increased free zinc induces the formation of ROS and RNS that subsequently induce further intracellular zinc release leading to cell death, showing a neurotoxic mechanism of positive feedback between free zinc and ROS/RNS.



Summary


Zinc has many indispensable roles in cellular and neuronal function. Levels of free zinc are tightly regulated by intracellular metal binding proteins and zinc transporters. While assiduously regulated under normal conditions, free zinc levels can rise rapidly under conditions of oxidative stress, wherein ROS and RNS liberate zinc from proteins, and the elevated zinc induces further ROS and RNS generation. Questions on the precise relationship between ROS/RNS, zinc, and calcium elevation remain, where the clarification of the ions’ respective roles in injury represent important future paths of investigation.

The neurotoxic relationship between increased intracellular zinc levels and the generation of ROS has many implications. Important among them is that the reactive species can induce zinc release and increased intracellular free zinc. This elevated zinc can then promote further elevation of ROS and RNS, demonstrating positive-feedback signaling that ultimately leads to cell death under an array of injury scenarios. Therapeutic interventions in these deleterious signaling cascades represent novel approaches at reducing the ROS/RNS and zinc accumulation-induced cell injury under a variety of excitotoxic scenarios.


Declaration of Conflict of Interest

The authors have no conflict of interest to declare.


References



1.

An C, Shi Y, Li P, Hu X, Gan Y, Stetler RA, Leak RK, Gao Y, Sun BL, Zheng P, Chen J (2014) Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol 115:6–24PubMedCentralCrossRefPubMed


2.

Andreini C, Banci L, Bertini I, Rosato A (2006) Counting the zinc-proteins encoded in the human genome. J Proteome Res 5:196–201CrossRefPubMed


3.

Andreini C, Bertini I (2012) A bioinformatics view of zinc enzymes. J Inorg Biochem 111:150–156CrossRefPubMed


4.

Aravindakumar CT, Ceulemans J, De Ley M (1999) Nitric oxide induces Zn2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiol. Biochem J 344(Pt 1):253–258PubMedCentralPubMed


5.

Berendji D, Kolb-Bachofen V, Meyer KL, Grapenthin O, Weber H, Wahn V, Kroncke KD (1997) Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Lett 405:37–41CrossRefPubMed


6.

Besser L, Chorin E, Sekler I, Silverman WF, Atkin S, Russell JT, Hershfinkel M (2009) Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J Neurosci Off J Soc Neurosci 29:2890–2901CrossRef


7.

Bossy-Wetzel E, Talantova MV, Lee WD, Scholzke MN, Harrop A, Mathews E, Gotz T, Han J, Ellisman MH, Perkins GA, Lipton SA (2004) Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 41:351–365CrossRefPubMed


8.

Brown AM, Kristal BS, Effron MS, Shestopalov AI, Ullucci PA, Sheu KF, Blass JP, Cooper AJ (2000) Zn2+ inhibits alpha-ketoglutarate-stimulated mitochondrial respiration and the isolated alpha-ketoglutarate dehydrogenase complex. J Biol Chem 275:13441–13447CrossRefPubMed


9.

Caldwell DF, Oberleas D, Clancy JJ, Prasad AS (1970) Behavioral impairment in adult rats following acute zinc deficiency. Proceedings of the Society for Experimental Biology and Medicine. Soc Exp Biol Med 133:1417–1421CrossRef


10.

Chen F, Qi Z, Luo Y, Hinchliffe T, Ding G, Xia Y, Ji X (2014) Non-pharmaceutical therapies for stroke: mechanisms and clinical implications. Prog Neurobiol 115:246–269CrossRefPubMed


11.

Clausen A, McClanahan T, Ji SG, Weiss JH (2013) Mechanisms of rapid reactive oxygen species generation in response to cytosolic Ca2+ or Zn2+ loads in cortical neurons. PLoS One 8, e83347PubMedCentralCrossRefPubMed


12.

Cole TB, Wenzel HJ, Kafer KE, Schwartzkroin PA, Palmiter RD (1999) Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci U S A 96:1716–1721PubMedCentralCrossRefPubMed


13.

Coleman JE (1992) Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 61:897–946CrossRefPubMed


14.

Colvin RA, Bush AI, Volitakis I, Fontaine CP, Thomas D, Kikuchi K, Holmes WR (2008) Insights into Zn2+ homeostasis in neurons from experimental and modeling studies. Am J Physiol Cell Physiol 294:C726–C742CrossRefPubMed


15.

Colvin RA, Fontaine CP, Laskowski M, Thomas D (2003) Zn2+ transporters and Zn2+ homeostasis in neurons. Eur J Pharmacol 479:171–185CrossRefPubMed


16.

Deng J, Lei C, Chen Y, Fang Z, Yang Q, Zhang H, Cai M, Shi L, Dong H, Xiong L (2014) Neuroprotective gases – fantasy or reality for clinical use? Prog Neurobiol 115:210–245CrossRefPubMed


17.

Domercq M, Mato S, Soria FN, Sanchez-gomez MV, Alberdi E, Matute C (2013) Zn2+ −induced ERK activation mediates PARP-1-dependent ischemic-reoxygenation damage to oligodendrocytes. Glia 61:383–393CrossRefPubMed


18.

Eide DJ (2006) Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763:711–722CrossRefPubMed


19.

Gazaryan IG, Krasinskaya IP, Kristal BS, Brown AM (2007) Zinc irreversibly damages major enzymes of energy production and antioxidant defense prior to mitochondrial permeability transition. J Biol Chem 282:24373–24380CrossRefPubMed


20.

Gazaryan IG, Krasnikov BF, Ashby GA, Thorneley RN, Kristal BS, Brown AM (2002) Zinc is a potent inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by lipoamide dehydrogenase. J Biol Chem 277:10064–10072CrossRefPubMed

Oct 22, 2016 | Posted by in NEUROSURGERY | Comments Off on Cytoplasmic Free Zinc and Increased Reactive Oxygen Species Generation in the Context of Brain Injury

Full access? Get Clinical Tree

Get Clinical Tree app for offline access